Ishita Drugs & Industries Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Ishita Drugs & Industries Ltd. on BSE

Search Inside the pdf :

30 Aug 2025

AGM

Ishita Drugs & Industries Ltd - 524400 - INTIMATION OF E- VOTING AS PER THE REGULATION …

BSE India

The E voting period for ensuing 32nd AGM which is to be held on 29th September, 2025 will commence from 26th September, 2025 (09:00 IST) and ends on 28th September, 2025 (05:00 IST) (both days inclusive) and cut off date for the same is 22nd September, 2025.

pdf

Ishita Drugs & Industries Ltd.

30 Aug 2025

Corp. Action

Ishita Drugs & Industries Ltd - 524400 - NTIMATION ABOUT THE BOOK CLOSURE FOR 32ND ANNUAL …

BSE India

We wish to inform you that Register of members and share transfer book of the Company remain closed from 23rd September, 2025 to 29th September, 2025 (both days Inclusive) for the purpose of Annual General Meeting of the Company.

pdf

Ishita Drugs & Industries Ltd.

28 Aug 2025

Company Update

Ishita Drugs & Industries Ltd - 524400 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition …

BSE India

Disclosure under Regulation 29(2) of SEBI(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal

pdf

Ishita Drugs & Industries Ltd.

28 Aug 2025

Company Update

Ishita Drugs & Industries Ltd - 524400 - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition …

BSE India

Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 received from Jagdish Agrawal

pdf

Ishita Drugs & Industries Ltd.

12 Aug 2025

Company Update

Ishita Drugs & Industries Ltd - 524400 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Board of Directors have approved the re-appointment of Mr. Arvind Vilasrao Sapkal (DIN: 08607096) as a non executive independent director for a second term of Five consecutive years, subject to the approval of shareholders of the Company.

pdf

Ishita Drugs & Industries Ltd.

12 Aug 2025

Result

Ishita Drugs & Industries Ltd - 524400 - Outcome Of Board Meeting Held On 12Th August, …

BSE India

Unaudited Financial Results of the company for the quarter ended 30th june, 2025 along with limited review report issued by the statutory auditor of the Company.

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	5.49	4.72	3.09	16.3%	77.7%
Operating Profit Qtr	0.35	0.29	0.17	20.7%	105.9%
Net Profit Qtr	0.30	0.29	0.15	3.4%	100.0%
Earning Per Share Adjusted latest Qtr	1.01	0.96	0.49	5.2%	106.1%

* Standalone data

Detailed Results

Ishita Drugs & Industries Ltd.

12 Aug 2025

Board Meeting

Ishita Drugs & Industries Ltd - 524400 - Board Meeting Outcome for Outcome Of Board Meeting …

BSE India

Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e. Tuesday, 12th August, 2025 have 1. Approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2025. The Limited Review Report issued by the Statutory Auditors of the Company enclosed herewith. 2. Approved the appointment of Mr. Arvind Vilasrao Sapkal (DIN- 08607096) as a Non- executive Independent Director of the Company, for a Second term of 5 (Five) consecutive years, which is subject to the approval of the shareholders of the Company. 3.Considered and approved the amendment in the Notice for convening the 32nd Annual General Meeting of the Company. 4. Board have approved the proposal to capitalize on any business opportunity in other field that may arise from time to time, provided the said business activity is included in MOA of the Company.

pdf

Ishita Drugs & Industries Ltd.

06 Aug 2025

Board Meeting

Ishita Drugs & Industries Ltd - 524400 - Board Meeting Intimation for Intimation Of Board Meeting …

BSE India

Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve 1. To consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended 30th June, 2025. 2. Any other matter with permission of the Chair.

pdf

Ishita Drugs & Industries Ltd.

08 Jul 2025

Company Update

Ishita Drugs & Industries Ltd - 524400 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2025 as attched.

pdf

Ishita Drugs & Industries Ltd.

27 Jun 2025

SAST

Ishita Drugs & Industries Ltd - 524400 - Closure of Trading Window

BSE India

The trading window for dealing in securities of the Company by designated persons stands closed from Tuesday, 1st July, 2025 till 48 hours after the declartion of the Unaudited Financial Results for the quarter ended 30th June, 2025

pdf

Is Ishita Drugs & Industries Ltd. worth buying?

11 Votes:

Buy 81.82%

Sell 9.09%

Hold 9.09%